Inactive Instrument

Analyst Reco. ITUS Corp OTC Bulletin Board

Equities

ITUS

US45069V1044

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Apr. 18	Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board	CI
Mar. 12	Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Nasdaq Futures Slip as Rate Rise Fears Weigh	23-06-08	DJ
HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating	23-03-23	MT
Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating	23-03-22	MT
Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target	22-12-23	MT
ANIXA BIOSCIENCES : HC Wainwright Starts Anixa Biosciences at Buy with $11 Price Target	21-04-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer